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Sir, 
Cancer patients make ample use of complementary and alternative
medicine (CAM), often being led to hope for a miracle cure (Ernst
and Cassileth, 1998). The advent of the internet renders patients all
the more vulnerable. Serious harm and even fatalities of cancer
patients following instructions for using CAM from the internet
are reported with depressing regularity (e.g. (Hainer et al, 2000)).
This short article is aimed at enhancing oncologists’ understanding
this complex area. 
Alternative cancer cures (ACCs) typically have a common life
cycle (Ernst, 2000). At the origin of almost every ACC is a charis-
matic individual who claims to have found the answer to cancer.
He (the male sex seems to dominate) often supports his claims
with pseudoscientific evidence referring to (but rarely presenting)
many cured patients. Thus he soon gathers ardent supporters who
lobby for a wider acceptance of this ACC. The pressure on the
medical establishment increases to a point where the treatment is
finally submitted to adequate testing. When the results turn out to
be negative, the ACC’s proponents argue that the investigations
were not done properly. In fact, they were set up to generate a
negative result so that the commercial interests of orthodoxy
would not be threatened. A conspiracy theory is thus born, and the
ACC lives on in the ‘alternative underground’. Henceforward the
gap between the two camps is destined to widen; mainstream
oncologists would claim that they have done their duty by submit-
ting the ACC to rigorous tests which have demonstrated it to be
useless. Supporters of the ACC dwell on their theory of a
conspiracy against them and continue to state that an effective cure
is being shamelessly suppressed. Both parties see themselves as
winners, but sadly, the loser often turns out to be the patient! 
Receiving a diagnosis of cancer is surely one of the most shat-
tering experiences one can possibly imagine. As soon as the initial
psychoemotional trauma is over, many patients want to assess their
options. This is when they access the world of ACCs, where the
most fantastic claims supported by seemingly compelling anec-
dotes and pseudoscience abound. It is easy to see how many
patients become deeply confused. Who can they turn to?
Unfortunately, help is hard to find. Oncologists are usually not
well informed about CAM and often dismiss the entire field
outright (Newell and Sanson-Fisher, 2000). This attitude can
confirm the above-mentioned conspiracy theory in the eyes of the
patient. CAM books are as plentiful as they are unreliable (Ernst
and Armstrong, 1998). Health food stores readily provide advice
but this information is primarily motivated by the desire to
increase sales and can put cancer patients at considerable risk
(Cook Gotay and Dumitriu, 2000). CAM providers are sympa-
thetic but can they be trusted? 
Patients thus face lonely and difficult decisions. Many opt to
follow the alternative route and invest in expensive, demanding,
ineffective and hazardous ACCs (e.g. (Hainer et al, 2000;
Richardson et al, 2000; von Gruenigen and Hopkins, 2000)) some-
times abandoning orthodox treatments altogether (e.g. (Hainer 
et al, 2000)). The decision to try CAM might be a marker either for
the psychological distress these patients feel (Burstein et al, 1999)
or for their active coping behaviour (Sollner et al, 2000). Of partic-
ular concern is the fact that, in about 50% of the cases, patients do
not inform their doctor about the decision to try CAM (e.g.
(Begbie et al, 1996; Boon et al, 2000)). 
Oncologists may react with surprise, anger, sadness or apathy.
They feel sure to know the truth: no single treatment is likely to
cure all cancers; the plausibility of these ACCs is close to zero; the
evidence is clearly against them (Ernst et al, 2001). Most impor-
tantly, they know that orthodox medicine is far from being a
conspiratory society; it would not hesitate in adopting a cancer
cure that is demonstrably effective, or test a treatment that holds
any reasonable promise at all. Thus, in the view of mainstream
oncologists, ACCs represent a contradiction in terms. The trouble
is, however, that many desperate cancer patients are not being
convinced. Perhaps they don’t want to be convinced, but may be
mainstream medicine is also bad at getting its points across? 
A lesson seems to emerge: doctors should ask their patients
about CAM-use, be informed about CAM, and openly pass on
their knowledge to their cancer patients, ensuring that they are
understood (Eisenberg, 1997). To achieve this we need empathy,
sympathy and time. Rather than damning all CAM outright, it
might be helpful to point out that some forms of CAM can be
useful not for curing cancer but for supportive and palliative
cancer care (Ernst, 2001). Insistence on taking the moral high
ground of ‘good science’ is probably counterproductive and may
constitute the very impetus that drives many patients towards
CAM. In that sense, every cancer patient harmed through an ACC
also represents a failure of orthodox medicine. 
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